28 November 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its final results for the third quarter of 2025 and the first nine months of 2025, thereby confirming the preliminary figures announced on 24 October 2025.
Preliminary figures for Q3/9M 2025 confirmed: sales for 9M 2025 at EUR 208.8 million, EBITDA reported at EUR 16.3 million
Focus on initiatives to optimise business processes and sustainably improve the capital and financing structure
Forecast for the 2025 financial year confirmed
View Q3 Interim Report
In the third quarter of the 2025 financial year, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 66.0 million (previous year: EUR 69.4 million), bringing sales for the first nine months of 2025 to EUR 208.8 million (previous year: EUR 212.7 million). While market conditions in many regions remained characterized by weak consumer sentiment, two newly launched fragrance collections provided positive momentum in September.
EBITDA reported for the third quarter of 2025 amounted to EUR 2.9 million (Q3 2024: EUR 7.3 million), primarily impacted by lower sales and higher marketing and sales expenses. Consequently, EBITDA reported for the first nine months of 2025 came in